King E, Horn D, Gluchowski N, OReilly D, Bruschettini M, Cooper C
Cochrane Database Syst Rev. 2025; 3:CD015127.
PMID: 40066936
PMC: 11895421.
DOI: 10.1002/14651858.CD015127.pub2.
Ho J, Kidman A, Chua B, Chang G, Fiander M, Davis P
Cochrane Database Syst Rev. 2024; 10:CD000143.
PMID: 39392114
PMC: 11469772.
DOI: 10.1002/14651858.CD000143.pub2.
Oliphant E, Hanning S, McKinlay C, Alsweiler J
J Perinatol. 2024; 44(6):785-801.
PMID: 38553606
PMC: 11161406.
DOI: 10.1038/s41372-024-01939-x.
Cramer S, Dekker J, Croughan M, Lee K, Crossley K, McGillick E
Pediatr Res. 2024; 96(2):325-331.
PMID: 38356025
DOI: 10.1038/s41390-024-03061-2.
Rodriguez-Duboc A, Basille-Dugay M, Debonne A, Riviere M, Vaudry D, Burel D
Curr Res Neurobiol. 2023; 5:100113.
PMID: 38020806
PMC: 10663136.
DOI: 10.1016/j.crneur.2023.100113.
Methylxanthine for the prevention and treatment of apnea in preterm infants.
Marques K, Bruschettini M, Roehr C, Davis P, Fiander M, Soll R
Cochrane Database Syst Rev. 2023; 10:CD013830.
PMID: 37905735
PMC: 10617014.
DOI: 10.1002/14651858.CD013830.pub2.
Doxapram for the prevention and treatment of apnea in preterm infants.
Evans S, Avdic E, Pessano S, Fiander M, Soll R, Bruschettini M
Cochrane Database Syst Rev. 2023; 10:CD014145.
PMID: 37877431
PMC: 10598592.
DOI: 10.1002/14651858.CD014145.pub2.
Maturation of cardioventilatory physiological trajectories in extremely preterm infants.
Weese-Mayer D, Di Fiore J, Lake D, Hibbs A, Claure N, Qiu J
Pediatr Res. 2023; 95(4):1060-1069.
PMID: 37857848
PMC: 11580183.
DOI: 10.1038/s41390-023-02839-0.
Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial).
Poppe J, Flint R, Smits A, Willemsen S, Storm K, Nuytemans D
Trials. 2023; 24(1):656.
PMID: 37817255
PMC: 10566117.
DOI: 10.1186/s13063-023-07683-5.
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Moresco L, Sjogren A, Marques K, Soll R, Bruschettini M
Cochrane Database Syst Rev. 2023; 10:CD015462.
PMID: 37791592
PMC: 10548499.
DOI: 10.1002/14651858.CD015462.pub2.
Developmental consequences of short apneas and periodic breathing in preterm infants.
Yee A, Siriwardhana L, Nixson G, Walter L, Wong F, Horne R
J Perinatol. 2023; 43(11):1420-1428.
PMID: 37558750
PMC: 10615736.
DOI: 10.1038/s41372-023-01748-8.
Continuous positive airway pressure (CPAP) for apnoea of prematurity.
Ho J, Zakarija-Grkovic I, Lok J, Lim E, Subramaniam P, Leong J
Cochrane Database Syst Rev. 2023; 7:CD013660.
PMID: 37481707
PMC: 10363278.
DOI: 10.1002/14651858.CD013660.pub2.
Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol.
Irimu G, Okwaro F, Coleman J, Waiyego M, Murila F, Chomba D
Implement Sci Commun. 2023; 4(1):80.
PMID: 37461120
PMC: 10351121.
DOI: 10.1186/s43058-023-00455-x.
Congenital Cataracts in Preterm Infants: A Review.
Al-Damri A, Alotaibi H
Cureus. 2023; 15(6):e40378.
PMID: 37456485
PMC: 10344420.
DOI: 10.7759/cureus.40378.
Cardiorespiratory Monitoring Data to Predict Respiratory Outcomes in Extremely Preterm Infants.
Ambalavanan N, Weese-Mayer D, Hibbs A, Claure N, Carroll J, Moorman J
Am J Respir Crit Care Med. 2023; 208(1):79-97.
PMID: 37219236
PMC: 10870840.
DOI: 10.1164/rccm.202210-1971OC.
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M, Brattstrom P, Russo C, Onland W, Davis P, Soll R
Cochrane Database Syst Rev. 2023; 4:CD013873.
PMID: 37040532
PMC: 10089673.
DOI: 10.1002/14651858.CD013873.pub2.
Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study.
Ambreen G, Kumar M, Ali A, Shah S, Saleem S, Tahir A
PLoS One. 2022; 17(11):e0275655.
PMID: 36350877
PMC: 9645656.
DOI: 10.1371/journal.pone.0275655.
Supplemental Oxygen Treats Periodic Breathing without Effects on Sleep in Late-Preterm Infants.
Seppa-Moilanen M, Andersson S, Kirjavainen T
Neonatology. 2022; 119(5):567-574.
PMID: 36088903
PMC: 9677840.
DOI: 10.1159/000525196.
Respiratory distress syndrome management in resource limited settings-Current evidence and opportunities in 2022.
Ekhaguere O, Okonkwo I, Batra M, Hedstrom A
Front Pediatr. 2022; 10:961509.
PMID: 35967574
PMC: 9372546.
DOI: 10.3389/fped.2022.961509.
Is Early Preventive Caffeine Safe and Effective in Premature Neonates? A Clinical Trial.
Sajjadian N, Taheri P, Jabbari M
Int J Pediatr. 2022; 2022:8701598.
PMID: 35692738
PMC: 9184212.
DOI: 10.1155/2022/8701598.
